Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study

Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study

Abstract Background An established treatment strategy for asymptomatic pulmonary embolism (PE) or deep vein thrombosis (DVT) remains uncertain in Japan; therefore, in this study, we clarify the characteristics and outcomes of symptomatic compared to asymptomatic patients with PE or DVT. Methods This...

Full description

Bibliographic Details
Main Authors: Shohei Migita, Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda, Takeshi Yamashita, Takanori Ikeda, Makoto Mo, Tsutomu Yamazaki, Atsushi Hirayama, on behalf of the J’xactly Investigators
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Thrombosis Journal
Subjects:
Anticoagulant
Bleeding
Recurrence
Rivaroxaban
Venous thromboembolism
Online Access:https://doi.org/10.1186/s12959-023-00528-w

Internet

https://doi.org/10.1186/s12959-023-00528-w

Similar Items